TD Private Client Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Sell |
4,838
-2,712
| -36% | -$1.1M | 0.05% | 243 |
|
|
2025
Q1 | $3.76M | Buy |
7,550
+1,332
| +21% | +$663K | 0.1% | 139 |
|
|
2024
Q4 | $3.23M | Sell |
6,218
-1,931
| -24% | -$1M | 0.09% | 165 |
|
|
2024
Q3 | $5.04M | Buy |
8,149
+1,591
| +24% | +$984K | 0.15% | 107 |
|
|
2024
Q2 | $3.63M | Buy |
6,558
+167
| +3% | +$92.3K | 0.11% | 136 |
|
|
2024
Q1 | $3.71M | Buy |
6,391
+369
| +6% | +$214K | 0.12% | 137 |
|
|
2023
Q4 | $3.2M | Sell |
6,022
-475
| -7% | -$252K | 0.12% | 146 |
|
|
2023
Q3 | $3.29M | Sell |
6,497
-2,444
| -27% | -$1.24M | 0.14% | 142 |
|
|
2023
Q2 | $4.66M | Sell |
8,941
-2,268
| -20% | -$1.18M | 0.2% | 111 |
|
|
2023
Q1 | $6.46M | Sell |
11,209
-1,394
| -11% | -$803K | 0.29% | 73 |
|
|
2022
Q4 | $6.97M | Sell |
12,603
-2,604
| -17% | -$1.44M | 0.33% | 60 |
|
|
2022
Q3 | $7.73M | Buy |
15,207
+366
| +2% | +$186K | 0.4% | 48 |
|
|
2022
Q2 | $8.08M | Sell |
14,841
-416
| -3% | -$226K | 0.39% | 48 |
|
|
2022
Q1 | $9.02M | Buy |
15,257
+551
| +4% | +$326K | 0.38% | 50 |
|
|
2021
Q4 | $9.81M | Sell |
14,706
-4,505
| -23% | -$3.01M | 0.41% | 48 |
|
|
2021
Q3 | $11M | Sell |
19,211
-873
| -4% | -$499K | 0.47% | 41 |
|
|
2021
Q2 | $10.1M | Sell |
20,084
-2,172
| -10% | -$1.1M | 0.43% | 46 |
|
|
2021
Q1 | $10.2M | Buy |
22,256
+686
| +3% | +$313K | 0.47% | 42 |
|
|
2020
Q4 | $10M | Sell |
21,570
-523
| -2% | -$244K | 0.51% | 40 |
|
|
2020
Q3 | $9.75M | Sell |
22,093
-226
| -1% | -$99.8K | 0.55% | 37 |
|
|
2020
Q2 | $8.09M | Buy |
22,319
+7,074
| +46% | +$2.56M | 0.47% | 46 |
|
|
2020
Q1 | $4.32M | Sell |
15,245
-1,284
| -8% | -$364K | 0.31% | 74 |
|
|
2019
Q4 | $5.37M | Buy |
+16,529
| New | +$5.37M | 0.32% | 75 |
|